Exclusive

Publication

Byline

Location

US Patent Issued to Innovstone Therapeutics on July 28 for "Compound having anti-tumor activity and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,252, issued on July 28, was assigned to Innovstone Therapeutics Ltd. (Shanghai). "Compound having anti-tumor activity and use thereof" was ... Read More


US Patent Issued to Curza Global, The University of Utah Research Foundation on July 28 for "Antimicrobial compounds and methods" (Italian, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,253, issued on July 28, was assigned to Curza Global LLC (Salt Lake City) and The University of Utah Research Foundation (Salt Lake City). ... Read More


US Patent Issued on July 28 for "Benzimidazole inhibitors of PAD enzymes" (New Jersey Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,254, issued on July 28. "Benzimidazole inhibitors of PAD enzymes" was invented by Khehyong Ngu (Pennington, N.J.). According to the abstra... Read More


US Patent Issued to UNIVERSITE DE GENEVE on July 28 for "Adenosine 2A receptor modulators for use in the treatment of cancer" (French, Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,255, issued on July 28, was assigned to UNIVERSITE DE GENEVE (Geneva). "Adenosine 2A receptor modulators for use in the treatment of cancer... Read More


US Patent Issued to BEIJING TIDE PHARMACEUTICAL on July 28 for "2,4,6-tri-substituted pyrimidine compounds as ATR kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,257, issued on July 28, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing). "2,4,6-tri-substituted pyrimidine compounds as ATR ... Read More


US Patent Issued to Daiichi Sankyo on July 28 for "Griseofulvin compound and pharmaceutical use thereof" (Japanese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,258, issued on July 28, was assigned to Daiichi Sankyo Co. Ltd. (Tokyo). "Griseofulvin compound and pharmaceutical use thereof" was invente... Read More


US Patent Issued to Emory University on July 28 for "Morpholine-containing and piperazine-containing CXCR4 modulators and uses related thereto" (Georgia Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,259, issued on July 28, was assigned to Emory University (Atlanta). "Morpholine-containing and piperazine-containing CXCR4 modulators and u... Read More


US Patent Issued to MEDIFRON DBT on July 28 for "Compound having inhibitory activity against O-glusacase and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,260, issued on July 28, was assigned to MEDIFRON DBT INC. (Seoul, South Korea). "Compound having inhibitory activity against O-glusacase an... Read More


US Patent Issued to Bayer, The Broad Institute, Dana-Farber Cancer Institute on July 28 for "Substituted heterocyclic compounds and therapeutic uses thereof" (German, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,261, issued on July 28, was assigned to Bayer AG (Leverkusen, Germany), The Broad Institute Inc. (Cambridge, Mass.) and Dana-Farber Cancer I... Read More


US Patent Issued to Merck Sharp & Dohme on July 28 for "Substituted ureas as orexin receptor agonists" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,262, issued on July 28, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Substituted ureas as orexin receptor agonists" was invente... Read More